Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients
- 30 November 2012
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 127 (2), 367-374
- https://doi.org/10.1016/j.ygyno.2012.07.001
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter StudyJournal of Clinical Oncology, 2011
- Thirty-Day Mortality After Primary Cytoreductive Surgery for Advanced Ovarian Cancer in the ElderlyObstetrics & Gynecology, 2011
- The Danish Register of Causes of DeathScandinavian Journal of Public Health, 2011
- A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer: A Multicentre Italian Trial in Ovarian cancer (MITO-5) studyCritical Reviews in Oncology/Hematology, 2008
- Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experienceInternational Journal of Gynecologic Cancer, 2007
- Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patientsInternational Journal of Gynecologic Cancer, 2007
- Ovarian cancer in younger vs older women: a population-based analysisBritish Journal of Cancer, 2006
- The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based studyGynecologic Oncology, 2005
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI Journal of the National Cancer Institute, 2000
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996